29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
2019 brought many changes and challenges to the world of labor and employment – and we expect 2020 ...
Read More >
Many employers strongly prefer arbitration to litigating with their employees in court. Employers of...
Read More >
Builders’ liens are a useful tool for unpaid contractors and subcontractors on a construction proje...
Read More >
On June 7, 2019, the Office of Environmental Health Hazard Assessment (OEHHA) announced that it has ...
Read More >
Weekly Wrap - Happy fall! The first week of autumn brought a busy legislature with it this week, as...
Read More >
The Third Circuit Court of Appeals recently issued an opinion that should serve as a warning not onl...
Read More >